Bioassay Directed Isolation, Biological Evaluation and in Silico Studies of New Isolates from <i>Pteris cretica</i> L.

• Asıl Yazarlar: Farooq Saleem (Yazar), Rashad Mehmood (Yazar), Saima Mehar (Yazar), Muhammad Tahir Javed Khan (Yazar), Zaheer- (Yazar), Muhammad Ashraf (Yazar), Muhammad Sajjad Ali (Yazar), Iskandar Abdullah (Yazar), Matheus Froeyen (Yazar), Muhammad Usman Mirza (Yazar), Sarfraz Ahmad (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2019-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.
• Notes: 2076-3921; 10.3390/antiox8070231
• Keywords: <i>Pteris cretica</i> L.; isolation; molecular docking; neurodegenerative; α-glucosidase; 2,2-diphenyl-1-picrylhydrazyl (DPPH); Therapeutics. Pharmacology; RM1-950
• Source: Antioxidants, Vol 8, Iss 7, p 231 (2019)

Members of genus <i>Pteris</i> have their established role in the traditional herbal medicine system. In the pursuit to identify its biologically active constituents, the specie <i>Pteris cretica</i> L. (<i>P. cretica</i>) was selected for the bioassay-guided isolation. Two new maleates (F9 and CB18) were identified from the chloroform extract and the structures of the isolates were elucidated through their spectroscopic data. The putative targets, that potentially interact with both of these isolates, were identified through reverse docking by using in silico tools PharmMapper and ReverseScreen3D. On the basis of reverse docking results, both isolates were screened for their antioxidant, acetylcholinesterase (AChE) inhibition, α-glucosidase (GluE) inhibition and antibacterial activities. Both isolates depicted moderate potential for the selected activities. Furthermore, docking studies of both isolates were also studied to investigate the binding mode with respective targets followed by molecular dynamics simulations and binding free energies. Thereby, the current study embodies the poly-pharmacological potential of <i>P. cretica</i>.